Yamashita Junji, Ogata Masaya, Itoh Makoto, Yamasowa Hiroshi, Shimeda Yuka, Takaoka Masanori, Matsumura Yasuo
Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan.
J Cardiovasc Pharmacol. 2003 Sep;42(3):419-27. doi: 10.1097/00005344-200309000-00014.
Possible involvement of nitric oxide (NO) in the protective effect of ischemic preconditioning against the ischemia/reperfusion-induced acute renal failure was investigated. Ischemic preconditioning, which consists of three cycles of 2-minute ischemia followed by 5-minute reperfusion, was performed prior to 45-minute ischemia. Ischemic preconditioning significantly improved the renal dysfunction induced by 45-minute ischemia followed by 24-hour reperfusion. Histopathological examination of the kidney of ischemia/reperfusion rats revealed severe renal damage, and suppression of the damage was seen with the ischemic preconditioning treatment. NO metabolites (NOx) production in the kidney after 45-minute ischemia and reperfusion was markedly increased in ischemia/reperfusion rats with ischemic preconditioning, compared with animals not subjected to ischemic preconditioning, and these increases correlated with changes in endothelial NO synthase (eNOS) protein expression in renal tissues. The improvement of renal dysfunction in ischemic preconditioning rats was abolished by the pretreatment with NG-nitro-L-arginine, a nonselective NOS inhibitor, but not with aminoguanidine, an inducible NOS inhibitor. In addition, increment of endothelin-1 (ET-1) content in the kidney after the reperfusion was markedly suppressed by ischemic preconditioning treatment. These findings suggest that the protective effect of ischemic preconditioning on ischemia/reperfusion -induced acute renal failure is closely related to the renal nitric oxide production following the increase in eNOS expression after the reperfusion and that the suppressive effect of ischemic preconditioning on the ischemia/reperfusion -induced renal ET-1 overproduction may be partly involved in the ameliorating effect of ischemic preconditioning.
研究了一氧化氮(NO)在缺血预处理对缺血/再灌注诱导的急性肾衰竭的保护作用中可能的参与情况。缺血预处理包括三个2分钟缺血后接5分钟再灌注的周期,在45分钟缺血之前进行。缺血预处理显著改善了45分钟缺血后接24小时再灌注所诱导的肾功能障碍。缺血/再灌注大鼠肾脏的组织病理学检查显示严重的肾损伤,而缺血预处理治疗可观察到损伤受到抑制。与未进行缺血预处理的动物相比,在进行缺血预处理的缺血/再灌注大鼠中,45分钟缺血和再灌注后肾脏中NO代谢产物(NOx)的产生显著增加,并且这些增加与肾组织中内皮型NO合酶(eNOS)蛋白表达的变化相关。用非选择性NOS抑制剂NG-硝基-L-精氨酸预处理可消除缺血预处理大鼠中肾功能障碍的改善,但用诱导型NOS抑制剂氨基胍预处理则不能。此外,缺血预处理治疗可显著抑制再灌注后肾脏中内皮素-1(ET-1)含量的增加。这些发现表明,缺血预处理对缺血/再灌注诱导的急性肾衰竭的保护作用与再灌注后eNOS表达增加后肾脏中NO的产生密切相关,并且缺血预处理对缺血/再灌注诱导的肾脏ET-1过量产生的抑制作用可能部分参与了缺血预处理的改善作用。